About
Metabolic Health Solutions (MHS) are an award winning, early-stage medical device and digital therapeutics company.
The company has developed and commercialised low cost metabolic testing technology and have integrated the technology into an effective managed care programme in Western Australia. The program is designed to support long-term weight management, through the use of specific metabolic diagnostic technology and a precision lifestyle management intervention. The program is delivered by allied health practitioners and current long-term data is very positive.
The company is now further developing the technology platform to include an AI assisted digital health management program ENABLE, designed to support the effective use of new therapeutic medications for obesity, specifically GLP1-A drugs. The ENABLE platform will provide diagnostic and management information to clinicians to ensure the effective use of these therapeutics and lifestyle prescription.
In 2024 MHS will commercialise the ENABLE platform in Australia and the UK, before a wider rollout scheduled for Q3 2025.
Find more information on Metabolic Health Solutions' website.
